US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) announced the retirement of Yihao Zhang, president and CEO of its China operations, effective July 1, 2025. Will Song, a Johnson & Johnson veteran with over 20 years of experience, will join the company on April 1, 2025, and has been named GE Healthcare’s new president and CEO for China, taking the helm from July 1.
Yihao Zhang’s Contributions
Since joining GE Healthcare in 2019, Yihao Zhang has been instrumental in driving the company’s strategic development and operations in China. He has led efforts to redefine the company’s localization, innovation, and partnership strategy in the country, establishing a clear blueprint for long – term growth in the region.
Will Song’s Background
Will Song previously served as global senior vice president and China chairman at Johnson & Johnson (J&J, NYSE: JNJ). He led the China Presidents’ Council to advance Johnson & Johnson’s innovation journey in China across MedTech and Innovative Medicine businesses. Since joining Johnson & Johnson in 2003, he has held various global positions with increasing responsibilities.-Fineline Info & Tech
Leave a Reply